News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs
Photo from ESMO/LinkedIn
Jun 26, 2024, 13:47

177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs

ESMO shared on LinkedIn:

“ESMOGI24: Promising data from the phase III NETTER-2 study show that peptide receptor radionuclide therapy significantly improves outcomes for patients with grade 2 high-grade 3 low gastroenteropancreatic neuroendocrine tumours (GEP-NETs), regardless of tumour grade or primary origin.

According to Rocio Garcia-Carbonero, commenting on these results for the ESMO Daily Reporter, this study supports the use of 177Lu-DOTATATE as a frontline treatment for somatostatin receptor-positive grade 3 low GEP-NETs, and possibly selected patients with grade 2 high GEP-NETs.”

Source: ESMO/LinkedIn

177Lu-DOTATATE cancer ESMO ESMO Daily Reporter ESMOGI24 NETTER-2 OncoDaily Oncology Rocio Garcia-Carbonero
Special Coverage
Blog
Feb 21, 2025, 12:29
The launch of the Access Cancer Treatment for Children initiative - Childhood Cancer International
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology
Blog
Feb 21, 2025, 10:45
Saurabh Zanwar: Clonal plasma cell proportion in the S-phase in multiple myeloma
Blog
Feb 21, 2025, 10:37
Cihangir Akyol: A comprehensive review on colorectal ESD outcomes by Lumir Kunovsky
Celebrities
Feb 21, 2025, 10:28
In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer